Infant Diet and Caregiver Resistome
IDCR
Breastfeeding and Its Impact on the Infant-caregiver Resistome
1 other identifier
observational
40
0 countries
N/A
Brief Summary
Antimicrobial resistance genes (ARGs) are the genes that allow bacteria to survive antibiotic treatments. These genes can be found in beneficial gut microbes, and occur more frequently in infants than adults. These genes can also transmit between different bacterial species. Exclusively breastfed infants carry fewer ARGs than formula fed infants. We are trying to find out if care-givers working with exclusively breastfed infants have fewer ARGs than those working with formula fed infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2026
CompletedFirst Posted
Study publicly available on registry
July 2, 2026
CompletedStudy Start
First participant enrolled
August 20, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 19, 2027
Study Completion
Last participant's last visit for all outcomes
May 31, 2029
July 2, 2026
June 1, 2026
12 months
June 26, 2026
June 26, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Count of antimicrobial resistance genes (ARGs) in stool
Count of ARGs in stool sample, and association with infant usual diet
2 weeks from enrollment
Abundance of antimicrobial resistance genes (ARGs)
Abundance of ARGs in stool samples from caregivers in relation to infant usual feeding practices
2 weeks from enrollment
Secondary Outcomes (3)
Count and diversity of antimicrobial resistance genes (ARGs) and caregiver diet
2 weeks from enrollment
Diversity and abundance of antimicrobial resistance genes (ARGs) and interactions
2 weeks
Caregiver gut microbiome
2 weeks
Interventions
We will collect stool samples and questionnaires on infant caregivers
Eligibility Criteria
Professional infant caregivers who work with infants at least 3 days a week for at least 6 hours per day who meet the inclusion and exclusion criteria of the sample.
You may qualify if:
- Employment at a childcare facility or home daycare at time of sampling
- Participant works and interacts with infants under the age 6 months old, including responsibility for changing diapers
- Participant \>18 years old
You may not qualify if:
- Participant has a history or presence of a medical condition including Ulcerative Colitis, Crohn's Disase, Inflammatory Bowel Disease, colon cancer, Celiac's disease, or other GI disordrs
- Current priobitic use or probiotic use within the last 4 weeks
- Participant is currently pregnant or breastfeeding
- Participant has an infant \<12 months old at home for 3 or more days per week
- Enrollment in a clinical trial involving an invstigational drug or dvic
- Antibiotic use within the past 3 months
- Participant working exclusively with infants \>6 months old at time of stool sample collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2026
First Posted
July 2, 2026
Study Start (Estimated)
August 20, 2026
Primary Completion (Estimated)
August 19, 2027
Study Completion (Estimated)
May 31, 2029
Last Updated
July 2, 2026
Record last verified: 2026-06